These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 10337924

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
    Koga M, Yuki N, Takahashi M, Saito K, Hirata K.
    J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.
    Hao Q, Saida T, Kuroki S, Nishimura M, Nukina M, Obayashi H, Saida K.
    J Neuroimmunol; 1998 Jan; 81(1-2):116-26. PubMed ID: 9521613
    [Abstract] [Full Text] [Related]

  • 5. Longitudinal changes of anti-ganglioside antibodies before and after Guillain-Barré syndrome onset subsequent to Campylobacter jejuni enteritis.
    Odaka M, Koga M, Yuki N, Susuki K, Hirata K.
    J Neurol Sci; 2003 Jun 15; 210(1-2):99-103. PubMed ID: 12736097
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis.
    Yuki N, Taki T, Handa S.
    J Neuroimmunol; 1996 Dec 15; 71(1-2):155-61. PubMed ID: 8982115
    [Abstract] [Full Text] [Related]

  • 8. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
    Funakoshi K, Koga M, Takahashi M, Hirata K, Yuki N.
    J Neurol Sci; 2006 Jul 15; 246(1-2):163-8. PubMed ID: 16600306
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Axonal Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni (PEN 43) enteritis].
    Ihara Y, Saito K, Yoshimoto S, Hayabara T, Yuki N.
    Rinsho Shinkeigaku; 1995 Aug 15; 35(8):901-3. PubMed ID: 8665735
    [Abstract] [Full Text] [Related]

  • 13. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
    Koga M, Gilbert M, Takahashi M, Li J, Koike S, Hirata K, Yuki N.
    J Infect Dis; 2006 Feb 15; 193(4):547-55. PubMed ID: 16425134
    [Abstract] [Full Text] [Related]

  • 14. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders.
    Enders U, Karch H, Toyka KV, Michels M, Zielasek J, Pette M, Heesemann J, Hartung HP.
    Ann Neurol; 1993 Aug 15; 34(2):136-44. PubMed ID: 8338338
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Longitudinal study of serum and cerebrospinal fluid (CSF) class-specific antibodies against Campylobacter jejuni and GM1 ganglioside in Guillain-Barré syndrome.
    Kimura F, Ito T, Yuki N, Nakajima H, Tanaka T, Shinoda K, Ohsawa N.
    Intern Med; 1995 Oct 15; 34(10):1009-14. PubMed ID: 8563080
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants.
    Koga M, Takahashi M, Yokoyama K, Kanda T.
    J Neurol; 2015 Aug 15; 262(8):1954-60. PubMed ID: 26050638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.